Fabin Han

810 total citations
29 papers, 516 citations indexed

About

Fabin Han is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Fabin Han has authored 29 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Fabin Han's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Fabin Han is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Fabin Han collaborates with scholars based in China, Canada and United States. Fabin Han's co-authors include David A. Grimes, Dennis E. Bulman, Lemuel Racacho, Anthony E. Lang, Michel Panisset, Ruobing Zou, Fengxia Xiao, Oksana Suchowersky, Juanli Chen and Daru Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Movement Disorders.

In The Last Decade

Fabin Han

28 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabin Han China 16 219 180 171 87 85 29 516
Lemuel Racacho Canada 14 192 0.9× 262 1.5× 164 1.0× 116 1.3× 80 0.9× 18 547
Lidia Tagliafierro United States 13 156 0.7× 291 1.6× 143 0.8× 79 0.9× 67 0.8× 18 558
Jay P. Ross Canada 15 241 1.1× 226 1.3× 111 0.6× 105 1.2× 50 0.6× 39 653
Cíntia Barros Santos-Rebouças Brazil 17 162 0.7× 378 2.1× 76 0.4× 311 3.6× 80 0.9× 64 767
M. Garrido Spain 12 196 0.9× 264 1.5× 151 0.9× 50 0.6× 19 0.2× 22 640
Niranjanan Nirmalananthan United Kingdom 11 177 0.8× 293 1.6× 159 0.9× 30 0.3× 28 0.3× 23 537
Shunling Guo United States 6 81 0.4× 199 1.1× 176 1.0× 188 2.2× 31 0.4× 6 533
Ko Sahashi Japan 16 289 1.3× 535 3.0× 247 1.4× 47 0.5× 33 0.4× 42 857
Michela Ripolone Italy 13 72 0.3× 349 1.9× 121 0.7× 63 0.7× 58 0.7× 40 526
R. Mazzei Italy 17 377 1.7× 254 1.4× 226 1.3× 59 0.7× 55 0.6× 51 748

Countries citing papers authored by Fabin Han

Since Specialization
Citations

This map shows the geographic impact of Fabin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabin Han more than expected).

Fields of papers citing papers by Fabin Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabin Han. The network helps show where Fabin Han may publish in the future.

Co-authorship network of co-authors of Fabin Han

This figure shows the co-authorship network connecting the top 25 collaborators of Fabin Han. A scholar is included among the top collaborators of Fabin Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabin Han. Fabin Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Yan, Yanming Liu, Wei Wang, et al.. (2024). Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson’s disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation. Stem Cell Research. 77. 103359–103359. 1 indexed citations
3.
Zheng, Yingying, et al.. (2024). PADI3 inhibits epithelial–mesenchymal transition by targeting CKS1-induced signal transduction in colon cancer. Journal of Cancer Research and Therapeutics. 20(4). 1323–1333. 2 indexed citations
5.
Song, Hao, Juanli Chen, Peng Sun, et al.. (2023). Epigenetic modification in Parkinson’s disease. Frontiers in Cell and Developmental Biology. 11. 1123621–1123621. 26 indexed citations
6.
Huang, Hongyun, John R. Bach, Hari Shanker Sharma, et al.. (2023). The 2022 yearbook of Neurorestoratology. Journal of Neurorestoratology. 11(2). 100054–100054. 21 indexed citations
7.
Huang, Hongyun, G.A. Moviglia, Hari Shanker Sharma, et al.. (2022). Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2022). SHILAP Revista de lepidopterología. 10(3). 100015–100015. 8 indexed citations
8.
Song, Na, Yan Wang, Junli Zhang, et al.. (2022). Genetic analysis of the LRP10 gene in Chinese patients with Parkinson’s disease. Neurological Sciences. 44(3). 905–912. 3 indexed citations
9.
Dai, Weibo, Yan Zheng, Pingsha Dong, et al.. (2022). Anxiolytic effect of YangshenDingzhi granules: Integrated network pharmacology and hippocampal metabolomics. Frontiers in Pharmacology. 13. 966218–966218. 8 indexed citations
10.
Zhang, Junli, et al.. (2022). Anticancer effects and mechanisms of astragaloside‑IV (Review). Oncology Reports. 49(1). 26 indexed citations
11.
Chen, Qingfa, Hao Song, Chuanguo Liu, et al.. (2020). The Interaction of EphA4 With PDGFRβ Regulates Proliferation and Neuronal Differentiation of Neural Progenitor Cells in vitro and Promotes Neurogenesis in vivo. Frontiers in Aging Neuroscience. 12. 17 indexed citations
12.
Han, Fabin, David A. Grimes, Fang Li, et al.. (2015). Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada. International Journal of Neuroscience. 126(5). 415–421. 19 indexed citations
13.
Yu, Zhe, Jun Xu, Wei Wang, et al.. (2014). Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson’s disease. Journal of Human Genetics. 60(2). 85–90. 31 indexed citations
14.
Han, Fabin, Lemuel Racacho, Anthony E. Lang, Dennis E. Bulman, & David A. Grimes. (2007). Refinement of the DYT15 locus in myoclonus dystonia. Movement Disorders. 22(6). 888–892. 27 indexed citations
15.
Han, Fabin, Lemuel Racacho, Howard H. Yang, et al.. (2007). Large deletions account for an increasing number of mutations in SGCE. Movement Disorders. 23(3). 456–460. 15 indexed citations
16.
Grimes, David A., Lemuel Racacho, Fabin Han, Michel Panisset, & Dennis E. Bulman. (2007). LRRK2 Screening in a Canadian Parkinson's Disease Cohort. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 34(3). 336–338. 9 indexed citations
17.
Han, Fabin, Dennis E. Bulman, Michel Panisset, & David A. Grimes. (2005). Neurofilament M gene in a French-Canadian Population with Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 32(1). 68–70. 8 indexed citations
18.
Grimes, David A., et al.. (2002). Hereditary chin trembling: A new family with exclusion of the chromosome 9q13‐q21 Locus. Movement Disorders. 17(6). 1390–1392. 19 indexed citations
19.
Grimes, David A., et al.. (2002). Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci. Movement Disorders. 17(6). 1205–1212. 2 indexed citations
20.
Lu, Daru, et al.. (1993). Stage I clinical trial of gene therapy for hemophilia B.. PubMed. 36(11). 1342–51. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026